Date
20 November 2018
Pharmariesen könnten mehr tun
Writing for Basler Zeitung, Patrick Griesser covers the results of the Foundation's latest Access to Medicine Index. The article highlights the industry's engagement in priority R&D and how the focus centres mainly on five diseases: malaria, HIV/AIDS, tuberculosis, Chagas disease and leishmaniasis.